Annual EPS
-$3.75
+$9.50+71.70%
December 31, 2023
Summary
- As of February 8, 2025, OCX annual earnings per share is -$3.75, with the most recent change of +$9.50 (+71.70%) on December 31, 2023.
- During the last 3 years, OCX annual EPS has risen by +$5.45 (+59.24%).
- OCX annual EPS is now at all-time high.
Performance
OCX EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EPS
-$0.98
-$0.62-172.22%
September 30, 2024
Summary
- As of February 8, 2025, OCX quarterly earnings per share is -$0.98, with the most recent change of -$0.62 (-172.22%) on September 30, 2024.
- Over the past year, OCX quarterly EPS has dropped by -$0.17 (-20.99%).
- OCX quarterly EPS is now -345.00% below its all-time high of $0.40, reached on March 31, 2023.
Performance
OCX Quarterly EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EPS
-$4.54
-$0.17-3.89%
September 30, 2024
Summary
- As of February 8, 2025, OCX TTM earnings per share is -$4.54, with the most recent change of -$0.17 (-3.89%) on September 30, 2024.
- Over the past year, OCX TTM EPS has increased by +$4.97 (+52.26%).
- OCX TTM EPS is now -27.89% below its all-time high of -$3.55, reached on December 31, 2023.
Performance
OCX TTM EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EPS Formula
EPS = Net Income - Preferred Dividends
Shares Outstanding
Net Income - Preferred Dividends
Shares Outstanding
Shares Outstanding
OCX EPS Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +71.7% | -21.0% | +52.3% |
| 3 y3 years | +59.2% | +33.8% | +68.7% |
| 5 y5 years | +55.4% | +33.8% | +68.7% |
OCX EPS Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +74.0% | -345.0% | +87.8% | -27.9% | +70.5% |
| 5 y | 5-year | at high | +74.0% | -345.0% | +87.8% | -27.9% | +70.5% |
| alltime | all time | at high | +75.6% | -345.0% | +87.8% | -27.9% | +70.5% |
OncoCyte EPS History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$0.98(+172.2%) | -$4.54(+3.9%) |
| Jun 2024 | - | -$0.36(-68.1%) | -$4.37(-14.0%) |
| Mar 2024 | - | -$1.13(-45.4%) | -$5.08(+43.1%) |
| Dec 2023 | -$3.75(-71.7%) | -$2.07(+155.6%) | -$3.55(-62.7%) |
| Sep 2023 | - | -$0.81(-24.3%) | -$9.51(-7.8%) |
| Jun 2023 | - | -$1.07(-367.5%) | -$10.32(-3.8%) |
| Mar 2023 | - | $0.40(-105.0%) | -$10.73(-19.5%) |
| Dec 2022 | -$13.25(-8.0%) | -$8.03(+395.7%) | -$13.33(+1.8%) |
| Sep 2022 | - | -$1.62(+9.5%) | -$13.10(-9.5%) |
| Jun 2022 | - | -$1.48(-32.7%) | -$14.48(-6.0%) |
| Mar 2022 | - | -$2.20(-71.8%) | -$15.40(+8.5%) |
| Dec 2021 | -$14.40(+56.5%) | -$7.80(+160.0%) | -$14.20(+73.2%) |
| Sep 2021 | - | -$3.00(+25.0%) | -$8.20(+13.9%) |
| Jun 2021 | - | -$2.40(+140.0%) | -$7.20(-5.3%) |
| Mar 2021 | - | -$1.00(-44.4%) | -$7.60(-17.4%) |
| Dec 2020 | -$9.20(+4.5%) | -$1.80(-10.0%) | -$9.20(-11.5%) |
| Sep 2020 | - | -$2.00(-28.6%) | -$10.40(0.0%) |
| Jun 2020 | - | -$2.80(+7.7%) | -$10.40(+7.5%) |
| Mar 2020 | - | -$2.60(-13.3%) | -$9.67(+11.5%) |
| Dec 2019 | -$8.80 | -$3.00(+50.0%) | -$8.67(+10.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2019 | - | -$2.00(-3.5%) | -$7.87(+8.3%) |
| Jun 2019 | - | -$2.07(+29.5%) | -$7.27(-4.3%) |
| Mar 2019 | - | -$1.60(-27.3%) | -$7.60(-9.5%) |
| Dec 2018 | -$8.40(-34.4%) | -$2.20(+57.1%) | -$8.40(-4.5%) |
| Sep 2018 | - | -$1.40(-41.7%) | -$8.80(-25.4%) |
| Jun 2018 | - | -$2.40(0.0%) | -$11.80(-1.7%) |
| Mar 2018 | - | -$2.40(-7.7%) | -$12.00(-6.3%) |
| Dec 2017 | -$12.80(+52.4%) | -$2.60(-40.9%) | -$12.80(+3.2%) |
| Sep 2017 | - | -$4.40(+69.2%) | -$12.40(+24.0%) |
| Jun 2017 | - | -$2.60(-18.8%) | -$10.00(+6.4%) |
| Mar 2017 | - | -$3.20(+45.5%) | -$9.40(+9.3%) |
| Dec 2016 | -$8.40(0.0%) | -$2.20(+10.0%) | -$8.60(-6.5%) |
| Sep 2016 | - | -$2.00(0.0%) | -$9.20(+1.1%) |
| Jun 2016 | - | -$2.00(-16.7%) | -$9.10(-20.5%) |
| Mar 2016 | - | -$2.40(-14.3%) | -$11.45(-13.7%) |
| Dec 2015 | -$8.40(-45.3%) | -$2.80(+47.1%) | -$13.27(-12.2%) |
| Sep 2015 | - | -$1.90(-56.2%) | -$15.11(+14.4%) |
| Jun 2015 | - | -$4.35(+3.1%) | -$13.21(+49.1%) |
| Mar 2015 | - | -$4.22(-9.2%) | -$8.86(+90.8%) |
| Dec 2014 | -$15.36(+42.7%) | -$4.64 | -$4.64 |
| Dec 2013 | -$10.77 | - | - |
FAQ
- What is OncoCyte annual earnings per share?
- What is the all time high annual EPS for OncoCyte?
- What is OncoCyte annual EPS year-on-year change?
- What is OncoCyte quarterly earnings per share?
- What is the all time high quarterly EPS for OncoCyte?
- What is OncoCyte quarterly EPS year-on-year change?
- What is OncoCyte TTM earnings per share?
- What is the all time high TTM EPS for OncoCyte?
- What is OncoCyte TTM EPS year-on-year change?
What is OncoCyte annual earnings per share?
The current annual EPS of OCX is -$3.75
What is the all time high annual EPS for OncoCyte?
OncoCyte all-time high annual earnings per share is -$3.75
What is OncoCyte annual EPS year-on-year change?
Over the past year, OCX annual earnings per share has changed by +$9.50 (+71.70%)
What is OncoCyte quarterly earnings per share?
The current quarterly EPS of OCX is -$0.98
What is the all time high quarterly EPS for OncoCyte?
OncoCyte all-time high quarterly earnings per share is $0.40
What is OncoCyte quarterly EPS year-on-year change?
Over the past year, OCX quarterly earnings per share has changed by -$0.17 (-20.99%)
What is OncoCyte TTM earnings per share?
The current TTM EPS of OCX is -$4.54
What is the all time high TTM EPS for OncoCyte?
OncoCyte all-time high TTM earnings per share is -$3.55
What is OncoCyte TTM EPS year-on-year change?
Over the past year, OCX TTM earnings per share has changed by +$4.97 (+52.26%)